Pharmafile Logo
Pharmafocus logo
Advanced Search
jose_baselga

AstraZeneca hire controversial cancer doc to head new Oncology R&D unit

January 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …

Appointment
heart-2372134_640

Two biomarkers can aid in atrial fibrillation screening, researchers find

January 8, 2019
Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …

News

Government unveils £20bn plan to revitalise NHS in England

January 8, 2019
Manufacturing and Production NHS funding, NHS< funding, brexit, government, health, policy

Theresa May and the chief executive of NHS England, Simon Stevens, have announced a new ten year plan for the …

News
takeda_global_hq

Takeda completes Shire acquisition

January 8, 2019
Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma

Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …

News
abbvie_0

AbbVie records an estimated $4billion in impairment charges after failure of cancer drug Rova-T

January 8, 2019
Manufacturing and Production AbbVie, M&A, MA, Stemcentrx, acquisition, rova-t

US firm AbbVie has said that it will record an estimated $4 billion in impairment charges related to the abandonment …

News
jallal

Immunocore names AstraZeneca exec as new CEO

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …

Appointment
mark_mallon

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …

Appointment
lilly_building_with_american_flag_web

Eli Lilly to buy Loxo Oncology in deal worth $8 billion

January 7, 2019
Manufacturing and Production Cancer, Eli Lilly, Loxo Oncology, gene therapy, personalised medicine

US firm Eli Lilly & Co today announced a definitive agreement for the acquisition of Connecticut-based company Loxo Oncology in …

News
cancer-vs-alzheimer-1080x810

Roche’s Genentech inks potential $2bn personalised cancer drug development deal

January 7, 2019
Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma

Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …

News

How tech is powering precision treatment

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …

Feature
shutterstock_36423250

Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt

January 7, 2019
Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease

Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …

News
astrazeneca_plaque

AstraZeneca loses two senior executives as biotechs appoint new CEOs

January 7, 2019
Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore

Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …

News

$400 billion in healthcare M&A deals expected for 2019

January 7, 2019
Sales and Marketing Hong Kong, M&A, MA, biotech, deals pharma, law, mergers

The coming year is set to see mergers and acquisitions in the healthcare sector worth more than $400 billion, according …

News
ipos0_l

Sanofi will pay Regeneron $582m in deal restructuring

January 7, 2019
Sales and Marketing Deals, Regeneron, Sanofi, biotech, pharma

French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …

News
stocks1

Aevi Genomic Medicine’s share price crashes 75% following ADHD trial failure

January 4, 2019
Medical Communications, Research and Development ADHD, AEVI-001, Aevi Genomic Medicine, clinical trial failure, pharma

Aevi Genomic Medicine, a US drugmaker based outside of Philadelphia, has seen its share value plummet by 75% following the …

News
astrazeneca_sign_sky

NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma

January 4, 2019
Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma

It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …

News
img_4190-e1376666350337-web

MHRA issues recall of irbesartan blood pressure meds over carcinogen contamination concerns

January 4, 2019
Manufacturing and Production, Medical Communications MHRA, irbesartan, pharma, sartan, valsartan

Following a number of recalls issued in the US and Europe in the latter half of 2018 for the blood …

News
takeda_usa_pharmaceuticals_u

Takeda unveils three new discovery and development collaborations in immuno-oncology

January 4, 2019
Medical Communications, Research and Development CAR-T, Crescendo Biologics, Memorial Sloan Kettering Cancer Center, Noile-Immune, Takeda, pharma

Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese …

News
shutterstock_273326141

BMS to acquire Celgene for $74 billion in biggest-ever pharma deal

January 4, 2019
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, acquisition, pharma

Starting off 2019 with a bang, Bristol-Myers Squibb has announced its intention to acquire fellow drugmaker Celgene as part of …

News

Children should be given flu vaccine to protect older people

December 21, 2018
Medical Communications epidemiology, flu, health, public health, vaccines

Parents are being urged to give their children the flu vaccine in order to protect ‘older people’ from the potentially …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026